← All peptides
Immune
Research Chemical

Chonluten

Also known as: Chonluten, T-34

Chonluten is a short synthetic peptide (Glu-Asp-Gly) studied as a bronchial and lung bioregulator. It belongs to the Khavinson family of short peptide bioregulators and is sometimes designated T-34.

Last updated

Mechanism of Action

Chonluten is a tripeptide (EDG) proposed to act as a tissue-specific bioregulator that binds DNA and modulates gene expression in bronchial epithelial and pulmonary cells. It is reported to influence expression of stress- and differentiation-related genes, supporting protection of respiratory epithelium against oxidative and toxic injury. By restoring homeostatic protein synthesis in lung tissue, it is studied for maintaining mucosal integrity and reducing local inflammatory burden.

Half-life
Short (minutes), consistent with rapid clearance of small tripeptides
Administration Routes
subcutaneous, intramuscular
Research Status
Research Chemical

Reported Benefits

  • Studied for support of bronchial and lung epithelial tissue
  • May protect respiratory epithelium against oxidative stress
  • Proposed to support normal mucosal differentiation
  • Investigated for modulation of local respiratory inflammation
  • Short peptide with generally low antigenicity

Potential Side Effects

  • Limited human safety data
  • Possible injection-site irritation
  • Potential hypersensitivity reactions
  • Unknown long-term effects

Common Dosing

For research use only and not medical advice: bioregulator references describe roughly 100-200 mcg daily subcutaneously or intramuscularly over 10-20 day cycles; no validated human dosing exists.

The dosing information above is aggregated from research literature and anecdotal community reports for educational purposes only. It is not a recommendation, prescription, or medical advice. Peptides are sold as research chemicals only and are not intended for human use.

Contraindications

  • Pregnancy and breastfeeding
  • Known peptide hypersensitivity
  • Acute respiratory infection or febrile illness without medical oversight
  • Peptides Regulating Proliferative Activity and Inflammatory Pathways in the Monocyte/Macrophage THP-1 Cell Line

    2022

    View
  • Peptidergic regulation of expression of genes encoding antioxidant and anti-inflammatory proteins

    2012

    View
  • Peptides: Prospects for Use in the Treatment of COVID-19

    2020

    View

It is a lung and bronchial peptide bioregulator studied for supporting respiratory epithelium and protecting it against oxidative and toxic stress.

No. It is an experimental short peptide backed mainly by the Russian bioregulator literature and is best considered a research chemical.

PeptideChat is for educational and research purposes only. Nothing on this site constitutes medical advice. Peptides are sold as research chemicals only and are not intended for human use. These statements have not been evaluated by the FDA and are not intended to diagnose, treat, cure, or prevent any disease. PeptideChat is an independent educational resource — not a pharmacy, compounding, or 503A/503B outsourcing facility — and does not sell products or provide medical advice.